{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:54:32Z","timestamp":1793087672721,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T00:00:00Z","timestamp":1346716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/nrrheum.2012.143","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T07:08:33Z","timestamp":1346742513000},"page":"13-23","source":"Crossref","is-referenced-by-count":407,"title":["Uric acid as a danger signal in gout and its comorbidities"],"prefix":"10.1038","volume":"9","author":[{"given":"Kenneth L.","family":"Rock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiann-Jyh","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,4]]},"reference":[{"key":"BFnrrheum2012143_CR1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Pandya, B. J. & Choi, H. K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum. 63, 3136\u20133141 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette, P. & Bardin, T. Gout. Lancet 375, 318\u2013328 (2010).","journal-title":"Lancet"},{"key":"BFnrrheum2012143_CR3","first-page":"199","volume":"68","author":"MH Pillinger","year":"2010","unstructured":"Pillinger, M. H., Goldfarb, D. S. & Keenan, R. T. Gout and its comorbidities. Bull. NYU Hosp. Jt Dis. 68, 199\u2013203 (2010).","journal-title":"Bull. NYU Hosp. Jt Dis."},{"key":"BFnrrheum2012143_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516\u2013521 (2003).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR5","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So, A. & Thorens, B. Uric acid transport and disease. J. Clin. Invest. 120, 1791\u20131799 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR6","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames, B. N., Cathcart, R., Schwiers, E. & Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl Acad. Sci. USA 78, 6858\u20136862 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000180910","volume":"19","author":"RA Frayha","year":"1977","unstructured":"Frayha, R. A., Salti, I. S., Arnaout, A., Khatchadurian, A. & Uthman, S. M. Hereditary xanthinuria: report on three patients and short review of the literature. Nephron 19, 328\u2013332 (1977).","journal-title":"Nephron"},{"key":"BFnrrheum2012143_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/1743132811Y.0000000074","volume":"34","author":"B Liu","year":"2012","unstructured":"Liu, B. et al. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurol. Res. 34, 163\u2013171 (2012).","journal-title":"Neurol. Res."},{"key":"BFnrrheum2012143_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","volume":"65","author":"MA Schwarzschild","year":"2008","unstructured":"Schwarzschild, M. A. et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch. Neurol. 65, 716\u2013723 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrrheum2012143_CR10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/keq204","volume":"49","author":"B Alvarez-Lario","year":"2010","unstructured":"Alvarez-Lario, B. & Macarron-Vicente, J. Uric acid and evolution. Rheumatology (Oxford) 49, 2010\u20132015 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012143_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.107.129031","volume":"324","author":"MK Kutzing","year":"2008","unstructured":"Kutzing, M. K. & Firestein, B. L. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 324, 1\u20137 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrrheum2012143_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/08830185.2010.529976","volume":"30","author":"H Kumar","year":"2011","unstructured":"Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16\u201334 (2011).","journal-title":"Int. Rev. Immunol."},{"key":"BFnrrheum2012143_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger, P. The danger model: a renewed sense of self. Science 296, 301\u2013305 (2002).","journal-title":"Science"},{"key":"BFnrrheum2012143_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","volume":"3","author":"KL Rock","year":"2008","unstructured":"Rock, K. L. & Kono, H. The inflammatory response to cell death. Annu. Rev. Pathol. 3, 99\u2013126 (2008).","journal-title":"Annu. Rev. Pathol."},{"key":"BFnrrheum2012143_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245\u2013252 (1998).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1615\/CritRevImmunol.v18.i5.10","volume":"18","author":"EA Greenfield","year":"1998","unstructured":"Greenfield, E. A., Nguyen, K. A. & Kuchroo, V. K. CD28\/B7 costimulation: a review. Crit. Rev. Immunol. 18, 389\u2013418 (1998).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnrrheum2012143_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00281-004-0173-3","volume":"26","author":"KL Rock","year":"2005","unstructured":"Rock, K. L., Hearn, A., Chen, C. J. & Shi, Y. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26, 231\u2013246 (2005).","journal-title":"Springer Semin. Immunopathol."},{"key":"BFnrrheum2012143_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/32183","volume":"392","author":"ML Albert","year":"1998","unstructured":"Albert, M. L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86\u201389 (1998).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR19","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.4049\/jimmunol.161.9.4467","volume":"161","author":"P Rovere","year":"1998","unstructured":"Rovere, P. et al. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161, 4467\u20134471 (1998).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR20","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/15200","volume":"5","author":"S Gallucci","year":"1999","unstructured":"Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249\u20131255 (1999).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012143_CR21","doi-asserted-by":"publisher","first-page":"14590","DOI":"10.1073\/pnas.260497597","volume":"97","author":"Y Shi","year":"2000","unstructured":"Shi, Y., Zheng, W. & Rock, K. L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl Acad. Sci. USA 97, 14590\u201314595 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR22","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1172\/JCI40124","volume":"120","author":"H Kono","year":"2010","unstructured":"Kono, H., Chen, C. J., Ontiveros, F. & Rock, K. L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939\u20131949 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2215","volume":"8","author":"H Kono","year":"2008","unstructured":"Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279\u2013289 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2012143_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.1780350310","volume":"35","author":"D Deapen","year":"1992","unstructured":"Deapen, D. et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 35, 311\u2013318 (1992).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR25","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.176.7.3905","volume":"176","author":"Y Shi","year":"2006","unstructured":"Shi, Y., Galusha, S. A. & Rock, K. L. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176, 3905\u20133908 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/BOR.0b013e3283025ed4","volume":"20","author":"R Allam","year":"2008","unstructured":"Allam, R. & Anders, H. J. The role of innate immunity in autoimmune tissue injury. Curr. Opin. Rheumatol. 20, 538\u2013544 (2008).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2012143_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.180605","volume":"193","author":"AA Like","year":"1976","unstructured":"Like, A. A. & Rossini, A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415\u2013417 (1976).","journal-title":"Science"},{"key":"BFnrrheum2012143_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1172\/JCI0211198","volume":"109","author":"MS Horwitz","year":"2002","unstructured":"Horwitz, M. S., Ilic, A., Fine, C., Rodriguez, E. & Sarvetnick, N. Presented antigen from damaged pancreatic \u03b2 cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109, 79\u201387 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1084\/jem.188.2.409","volume":"188","author":"C Kurts","year":"1998","unstructured":"Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R. & Heath, W. R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188, 409\u2013414 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012143_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm0798-781","volume":"4","author":"MS Horwitz","year":"1998","unstructured":"Horwitz, M. S. et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4, 781\u2013785 (1998).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012143_CR31","volume-title":"Cells, tissues, and disease: principles of general pathology","author":"G Majno","year":"2004","unstructured":"Majno, G. & Joris, I. Cells, tissues, and disease: principles of general pathology 2nd edn (Oxford University Press, New York, 2004)."},{"key":"BFnrrheum2012143_CR32","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.4049\/jimmunol.0902485","volume":"184","author":"H Kono","year":"2010","unstructured":"Kono, H., Karmarkar, D., Iwakura, Y. & Rock, K. L. Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J. Immunol. 184, 4470\u20134478 (2010).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","volume":"28","author":"KL Rock","year":"2010","unstructured":"Rock, K. L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annu. Rev. Immunol. 28, 321\u2013342 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2012143_CR34","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","volume":"36","author":"M Mertens","year":"2009","unstructured":"Mertens, M. & Singh, J. A. Anakinra for rheumatoid arthritis: a systematic review. J. Rheumatol. 36, 1118\u20131125 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2012143_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-065X.2011.01040.x","volume":"243","author":"KL Rock","year":"2011","unstructured":"Rock, K. L., Lai, J. J. & Kono, H. Innate and adaptive immune responses to cell death. Immunol. Rev. 243, 191\u2013205 (2011).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum2012143_CR36","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1172\/JCI28075","volume":"116","author":"CJ Chen","year":"2006","unstructured":"Chen, C. J. et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116, 2262\u20132271 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","volume":"179","author":"P Gasse","year":"2009","unstructured":"Gasse, P. et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179, 903\u2013913 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrrheum2012143_CR38","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720\u20133732 (2011).","journal-title":"Blood"},{"key":"BFnrrheum2012143_CR39","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.4049\/jimmunol.181.12.8194","volume":"181","author":"T Eigenbrod","year":"2008","unstructured":"Eigenbrod, T., Park, J. H., Harder, J., Iwakura, Y. & Nunez, G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1\u03b1 released from dying cells. J. Immunol. 181, 8194\u20138198 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","volume":"36","author":"O Gross","year":"2012","unstructured":"Gross, O. et al. Inflammasome activators induce interleukin-1\u03b1 secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36, 388\u2013400 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2012143_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello, C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519\u2013550 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2012143_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind, F. G. et al. Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787\u2013791 (2009).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol. Cell 10, 417\u2013426 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrrheum2012143_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"BFnrrheum2012143_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle\u2013Wells syndrome. Nat. Genet. 29, 301\u2013305 (2001).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2012143_CR46","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich, I. et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46, 3340\u20133348 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/s10165-009-0271-0","volume":"20","author":"T Kubota","year":"2010","unstructured":"Kubota, T. & Koike, R. Cryopyrin-associated periodic syndromes: background and therapeutics. Mod. Rheumatol. 20, 213\u2013221 (2010).","journal-title":"Mod. Rheumatol."},{"key":"BFnrrheum2012143_CR48","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00281-006-0015-6","volume":"27","author":"LD Church","year":"2006","unstructured":"Church, L. D., Churchman, S. M., Hawkins, P. N. & McDermott, M. F. Hereditary auto-inflammatory disorders and biologics. Springer Semin. Immunopathol. 27, 494\u2013508 (2006).","journal-title":"Springer Semin. Immunopathol."},{"key":"BFnrrheum2012143_CR49","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1073\/pnas.87.14.5548","volume":"87","author":"Y Kobayashi","year":"1990","unstructured":"Kobayashi, Y. et al. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1\u03b1. Proc. Natl Acad. Sci. USA 87, 5548\u20135552 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2011.07.037","volume":"44","author":"IS Afonina","year":"2011","unstructured":"Afonina, I. S. et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1\u03b1. Mol. Cell 44, 265\u2013278 (2011).","journal-title":"Mol. Cell"},{"key":"BFnrrheum2012143_CR51","doi-asserted-by":"publisher","first-page":"18055","DOI":"10.1073\/pnas.1109176108","volume":"108","author":"A Fettelschoss","year":"2011","unstructured":"Fettelschoss, A. et al. Inflammasome activation and IL-1\u03b2 target IL-1\u03b1 for secretion as opposed to surface expression. Proc. Natl Acad. Sci. USA 108, 18055\u201318060 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR52","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1126\/science.7535475","volume":"267","author":"K Kuida","year":"1995","unstructured":"Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1\u03b2 converting enzyme. Science 267, 2000\u20132003 (1995).","journal-title":"Science"},{"key":"BFnrrheum2012143_CR53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","volume":"24","author":"FS Sutterwala","year":"2006","unstructured":"Sutterwala, F. S. et al. Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317\u2013327 (2006).","journal-title":"Immunity"},{"key":"BFnrrheum2012143_CR54","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2012143_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","volume":"22","author":"E Latz","year":"2010","unstructured":"Latz, E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 22, 28\u201333 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrrheum2012143_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","volume":"10","author":"G Nuki","year":"2008","unstructured":"Nuki, G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr. Rheumatol. Rep. 10, 218\u2013227 (2008).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. S2","key":"BFnrrheum2012143_CR57","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1002\/art.23069","volume":"58","author":"DJ McCarty","year":"2008","unstructured":"McCarty, D. J. Urate crystals, inflammation, and colchicine. Arthritis Rheum. 58 (Suppl. S2), S20\u2013S24 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR58","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","volume":"453","author":"SC Eisenbarth","year":"2008","unstructured":"Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the NALP3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122\u20131126 (2008).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR60","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1172\/JCI118147","volume":"96","author":"BN Cronstein","year":"1995","unstructured":"Cronstein, B. N. et al. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J. Clin. Invest. 96, 994\u20131002 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR61","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert, C. et al. Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science 320, 674\u2013677 (2008).","journal-title":"Science"},{"key":"BFnrrheum2012143_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2012143_CR63","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00018-010-0567-4","volume":"68","author":"F Bauernfeind","year":"2011","unstructured":"Bauernfeind, F. et al. Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci. 68, 765\u2013783 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrrheum2012143_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR65","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2012143_CR66","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2012143_CR67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj.cdd.4401264","volume":"10","author":"H Hentze","year":"2003","unstructured":"Hentze, H., Lin, X. Y., Choi, M. S. & Porter, A. G. Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ. 10, 956\u2013968 (2003).","journal-title":"Cell Death Differ."},{"key":"BFnrrheum2012143_CR68","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1073\/pnas.0804897106","volume":"106","author":"FA Sharp","year":"2009","unstructured":"Sharp, F. A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl Acad. Sci. USA 106, 870\u2013875 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR69","doi-asserted-by":"publisher","first-page":"e6510","DOI":"10.1371\/journal.pone.0006510","volume":"4","author":"C Dostert","year":"2009","unstructured":"Dostert, C. et al. Malarial hemozoin is a NALP3 inflammasome activating danger signal. PLoS ONE 4, e6510 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2012143_CR70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature07965","volume":"459","author":"O Gross","year":"2009","unstructured":"Gross, O. et al. Syk kinase signalling couples to the NLRP3 inflammasome for anti-fungal host defence. Nature 459, 433\u2013436 (2009).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.1780180213","volume":"18","author":"S Hoffstein","year":"1975","unstructured":"Hoffstein, S. & Weissmann, G. Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthritis Rheum. 18, 153\u2013165 (1975).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR72","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","volume":"14","author":"V Petrilli","year":"2007","unstructured":"Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583\u20131589 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnrrheum2012143_CR73","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826\u2013837 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2012143_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2011.01043.x","volume":"243","author":"JC Leemans","year":"2011","unstructured":"Leemans, J. C., Cassel, S. L. & Sutterwala, F. S. Sensing damage by the NLRP3 inflammasome. Immunol. Rev. 243, 152\u2013162 (2011).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum2012143_CR75","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401\u2013414 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2012143_CR76","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.25006","volume":"60","author":"LA Joosten","year":"2009","unstructured":"Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1\u03b2. Arthritis Rheum. 60, 3651\u20133662 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR77","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/art.24959","volume":"60","author":"M Guma","year":"2009","unstructured":"Guma, M. et al. Caspase 1-independent activation of interleukin-1\u03b2 in neutrophil-predominant inflammation. Arthritis Rheum. 60, 3642\u20133650 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR78","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1016\/S0021-9258(19)39328-7","volume":"265","author":"DJ Hazuda","year":"1990","unstructured":"Hazuda, D. J., Strickler, J., Kueppers, F., Simon, P. L. & Young, P. R. Processing of precursor interleukin 1\u03b2 and inflammatory disease. J. Biol. Chem. 265, 6318\u20136322 (1990).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012143_CR79","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1084\/jem.174.4.821","volume":"174","author":"H Mizutani","year":"1991","unstructured":"Mizutani, H., Schechter, N., Lazarus, G., Black, R. A. & Kupper, T. S. Rapid and specific conversion of precursor interleukin 1\u03b2 (IL-1\u03b2) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174, 821\u2013825 (1991).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012143_CR80","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U Schonbeck","year":"1998","unstructured":"Schonbeck, U., Mach, F. & Libby, P. Generation of biologically active IL-1\u03b2 by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1\u03b2 processing. J. Immunol. 161, 3340\u20133346 (1998).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR81","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","volume":"96","author":"C Coeshott","year":"1999","unstructured":"Coeshott, C. et al. Converting enzyme-independent release of tumor necrosis factor \u03b1 and IL-1\u03b2 from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl Acad. Sci. USA 96, 6261\u20136266 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR82","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","volume":"96","author":"CT Pham","year":"1999","unstructured":"Pham, C. T. & Ley, T. J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl Acad. Sci. USA 96, 8627\u20138632 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR83","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/S0021-9258(18)53798-4","volume":"268","author":"MJ McGuire","year":"1993","unstructured":"McGuire, M. J., Lipsky, P. E. & Thiele, D. L. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J. Biol. Chem. 268, 2458\u20132467 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012143_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI0213462","volume":"109","author":"AM Adkison","year":"2002","unstructured":"Adkison, A. M., Raptis, S. Z., Kelley, D. G. & Pham, C. T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 109, 363\u2013371 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012143_CR85","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","volume":"174","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R., Pritzker, K., Firestein, G. S. & Terkeltaub, R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J. Immunol. 174, 5016\u20135023 (2005).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR86","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten, L. A. et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62, 3237\u20133248 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR87","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.immuni.2008.09.013","volume":"29","author":"G Ng","year":"2008","unstructured":"Ng, G. et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 29, 807\u2013818 (2008).","journal-title":"Immunity"},{"key":"BFnrrheum2012143_CR88","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","volume":"177","author":"P Scott","year":"2006","unstructured":"Scott, P., Ma, H., Viriyakosol, S., Terkeltaub, R. & Liu-Bryan, R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J. Immunol. 177, 6370\u20136378 (2006).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR89","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.4049\/jimmunol.0900906","volume":"183","author":"O Popa-Nita","year":"2009","unstructured":"Popa-Nita, O., Proulx, S., Pare, G., Rollet-Labelle, E. & Naccache, P. H. Crystal-induced neutrophil activation: XI. Implication and novel roles of classical protein kinase C. J. Immunol. 183, 2104\u20132114 (2009).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR90","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.20386","volume":"50","author":"N Tramontini","year":"2004","unstructured":"Tramontini, N., Huber, C., Liu-Bryan, R., Terkeltaub, R. A. & Kilgore, K. S. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum. 50, 2633\u20132639 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR91","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","volume":"91","author":"M Pouliot","year":"1998","unstructured":"Pouliot, M., James, M. J., McColl, S. R., Naccache, P. H. & Cleland, L. G. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 91, 1769\u20131776 (1998).","journal-title":"Blood"},{"key":"BFnrrheum2012143_CR92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.immuni.2011.03.019","volume":"34","author":"E Kuroda","year":"2011","unstructured":"Kuroda, E. et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 34, 514\u2013526 (2011).","journal-title":"Immunity"},{"key":"BFnrrheum2012143_CR93","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/rheumatology\/keq037","volume":"49","author":"E Krishnan","year":"2010","unstructured":"Krishnan, E. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 49, 1229\u20131238 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum2012143_CR94","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/15257770.2011.596499","volume":"30","author":"N Ichikawa","year":"2011","unstructured":"Ichikawa, N., Taniguchi, A., Urano, W., Nakajima, A. & Yamanaka, H. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids 30, 1045\u20131050 (2011).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"BFnrrheum2012143_CR95","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla, U. M. et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 67, 1739\u20131742 (2005).","journal-title":"Kidney Int."},{"key":"BFnrrheum2012143_CR96","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali, M. et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38, 1101\u20131106 (2001).","journal-title":"Hypertension"},{"key":"BFnrrheum2012143_CR97","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali, M. et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am. J. Physiol. Renal Physiol. 282, F991\u2013F997 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrrheum2012143_CR98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","volume":"106","author":"CA Farquharson","year":"2002","unstructured":"Farquharson, C. A., Butler, R., Hill, A., Belch, J. J. & Struthers, A. D. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106, 221\u2013226 (2002).","journal-title":"Circulation"},{"key":"BFnrrheum2012143_CR99","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ceca.2012.01.003","volume":"51","author":"Q Hong","year":"2012","unstructured":"Hong, Q. et al. Hyperuricemia induces endothelial dysfunction via mitochondrial Na+\/Ca2+ exchanger-mediated mitochondrial calcium overload. Cell Calcium 51, 402\u2013410 (2012).","journal-title":"Cell Calcium"},{"key":"BFnrrheum2012143_CR100","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","volume":"59","author":"P Puddu","year":"2012","unstructured":"Puddu, P., Puddu, G. M., Cravero, E., Vizioli, L. & Muscari, A. The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications. J. Cardiol. 59, 235\u2013242 (2012).","journal-title":"J. Cardiol."},{"key":"BFnrrheum2012143_CR101","doi-asserted-by":"publisher","first-page":"C1183","DOI":"10.1152\/ajpcell.00075.2008","volume":"295","author":"S Zharikov","year":"2008","unstructured":"Zharikov, S. et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am. J. Physiol. Cell Physiol. 295, C1183\u2013C1190 (2008).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrrheum2012143_CR102","doi-asserted-by":"publisher","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","volume":"290","author":"T Nakagawa","year":"2006","unstructured":"Nakagawa, T. et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol. 290, F625\u2013F631 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrrheum2012143_CR103","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179\u2013188 (2011).","journal-title":"Nat. Med."},{"key":"BFnrrheum2012143_CR104","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"BFnrrheum2012143_CR105","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0022-2143(97)90178-5","volume":"129","author":"GN Dalekos","year":"1997","unstructured":"Dalekos, G. N., Elisaf, M., Bairaktari, E., Tsolas, O. & Siamopoulos, K. C. Increased serum levels of interleukin-1\u03b2 in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? J. Lab. Clin. Med. 129, 300\u2013308 (1997).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrrheum2012143_CR106","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1365-2362.1996.tb02141.x","volume":"26","author":"GN Dalekos","year":"1996","unstructured":"Dalekos, G. N., Elisaf, M. S., Papagalanis, N., Tzallas, C. & Siamopoulos, K. C. Elevated interleukin-1\u03b2 in the circulation of patients with essential hypertension before any drug therapy: a pilot study. Eur. J. Clin. Invest. 26, 936\u2013939 (1996).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrrheum2012143_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2362.2001.00743.x","volume":"31","author":"AC Peeters","year":"2001","unstructured":"Peeters, A. C. et al. Pro-inflammatory cytokines in patients with essential hypertension. Eur. J. Clin. Invest. 31, 31\u201336 (2001).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrrheum2012143_CR108","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero, C. et al. Uric acid and inflammatory markers. Eur. Heart J. 27, 1174\u20131181 (2006).","journal-title":"Eur. Heart J."},{"key":"BFnrrheum2012143_CR109","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.atherosclerosis.2008.05.047","volume":"203","author":"J Vekic","year":"2009","unstructured":"Vekic, J. et al. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis 203, 236\u2013242 (2009).","journal-title":"Atherosclerosis"},{"key":"BFnrrheum2012143_CR110","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1136\/ard.2010.144774","volume":"70","author":"A Chhana","year":"2011","unstructured":"Chhana, A. et al. Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout. Ann. Rheum. Dis. 70, 1684\u20131691 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012143_CR111","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1136\/ard.2010.128454","volume":"69","author":"N Schlesinger","year":"2010","unstructured":"Schlesinger, N. & Thiele, R. G. The pathogenesis of bone erosions in gouty arthritis. Ann. Rheum. Dis. 69, 1907\u20131912 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012143_CR112","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So, A., De Smedt, T., Revaz, S. & Tschopp, J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9, R28 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012143_CR113","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/art.33412","volume":"64","author":"HR Schumacher Jr.","year":"2012","unstructured":"Schumacher, H. R. Jr. et al. Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64, 876\u2013884 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR114","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/ard.2010.144063","volume":"70","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger, N. et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann. Rheum. Dis. 70, 1264\u20131271 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2012143_CR115","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar3297","volume":"13","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger, N. et al. Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation: results of a randomized, dose-ranging study. Arthritis Res. Ther. 13, R53 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012143_CR116","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/art.27600","volume":"62","author":"A So","year":"2010","unstructured":"So, A. et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 62, 3064\u20133076 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR117","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1126\/science.133.3449.307","volume":"133","author":"FM Burnet","year":"1961","unstructured":"Burnet, F. M. Immunological recognition of self. Science 133, 307\u2013311 (1961).","journal-title":"Science"},{"key":"BFnrrheum2012143_CR118","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-065X.1999.tb01355.x","volume":"172","author":"IA York","year":"1999","unstructured":"York, I. A., Goldberg, A. L., Mo, X. Y. & Rock, K. L. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172, 49\u201366 (1999).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum2012143_CR119","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev.iy.11.040193.002155","volume":"11","author":"RN Germain","year":"1993","unstructured":"Germain, R. N. & Margulies, D. H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11, 403\u2013450 (1993).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2012143_CR120","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/art.27456","volume":"62","author":"HM Hoffman","year":"2010","unstructured":"Hoffman, H. M. et al. Role of the leucine-rich repeat domain of cryopyrin\/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum. 62, 2170\u20132179 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR121","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/ard.2009.109355","volume":"68","author":"R Torres","year":"2009","unstructured":"Torres, R. et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann. Rheum. Dis 68, 1602\u20131608 (2009).","journal-title":"Ann. Rheum. Dis"},{"key":"BFnrrheum2012143_CR122","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1073\/pnas.0803933105","volume":"105","author":"SL Cassel","year":"2008","unstructured":"Cassel, S. L. et al. The NALP3 inflammasome is essential for the development of silicosis. Proc. Natl Acad. Sci. USA 105, 9035\u20139040 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR123","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.1021\/nn200595c","volume":"5","author":"J Palomaki","year":"2011","unstructured":"Palomaki, J. et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5, 6861\u20136870 (2011).","journal-title":"ACS Nano"},{"key":"BFnrrheum2012143_CR124","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5, e11765 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2012143_CR125","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","volume":"181","author":"H Li","year":"2008","unstructured":"Li, H., Willingham, S. B., Ting, J. P. & Re, F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181, 17\u201321 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR126","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/eji.200838549","volume":"38","author":"L Franchi","year":"2008","unstructured":"Franchi, L. & Nunez, G. The NLRP3 inflammasome is critical for aluminium hydroxide-mediated IL-1\u03b2 secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38, 2085\u20132089 (2008).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2012143_CR127","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.181.6.3755","volume":"181","author":"M Kool","year":"2008","unstructured":"Kool, M. et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181, 3755\u20133759 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR128","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","volume":"186","author":"B Pazar","year":"2011","unstructured":"Pazar, B. et al. Basic calcium phosphate crystals induce monocyte\/macrophage IL-1\u03b2 secretion through the NLRP3 inflammasome in vitro. J. Immunol. 186, 2495\u20132502 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum2012143_CR129","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/art.30147","volume":"63","author":"S Narayan","year":"2011","unstructured":"Narayan, S. et al. Octacalcium phosphate crystals induce inflammation in vivo through interleukin-1 but independent of the NLRP3 inflammasome in mice. Arthritis Rheum. 63, 422\u2013433 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012143_CR130","doi-asserted-by":"publisher","first-page":"14867","DOI":"10.1073\/pnas.1111101108","volume":"108","author":"C Jin","year":"2011","unstructured":"Jin, C. et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc. Natl Acad. Sci. USA 108, 14867\u201314872 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2012143_CR131","doi-asserted-by":"publisher","first-page":"19449","DOI":"10.1073\/pnas.1008155107","volume":"107","author":"AS Yazdi","year":"2010","unstructured":"Yazdi, A. S. et al. Nanoparticles activate the NLR pyrin domain containing 3 (NLRP3) inflammasome and cause pulmonary inflammation through release of IL-1\u03b1 and IL-1\u03b2. Proc. Natl Acad. Sci. USA 107, 19449\u201319454 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T22:25:49Z","timestamp":1714343149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2012.143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,4]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFnrrheum2012143"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2012.143","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,4]]}}}